Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer
Abstract Background Advanced gastric cancer has an unfavorable prognosis and poor curability. Immune checkpoint inhibitors, such as nivolumab, have recently emerged as a potential solution for this aggressive disease. However, there is a lack of established evidence on the clinical efficacy of these...
Saved in:
| Main Authors: | Chen Jun, Suguru Yamauchi, Yukinori Yube, Hiroki Egawa, Yutaro Yoshimoto, Akira Kubota, Kenki Tsuda, Sanae Kaji, Hajime Orita, Shinichi Oka, Shinji Mine, Tetsu Fukunaga |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Japan Surgical Society
2023-05-01
|
| Series: | Surgical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40792-023-01668-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A vanished gastric gastrointestinal stromal tumor
by: Sarah Honjo, et al.
Published: (2023-05-01) -
Bullous pemphigoid associated with the use of nivolumab in a patient with metastatic melanoma: a case report.
by: Diego Lopes Paim Miranda, et al.
Published: (2020-01-01) -
Nivolumab-induced interstitial lung disease in the patient with melanoma
by: Marcin Morawski, et al.
Published: (2024-02-01) -
Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso
by: Maria Victoria Foglino, et al.
Published: (2025-07-01) -
Nivolumab in two cases of refractory mycosis fungoides erythroderma
by: Ewa Chmielowska
Published: (2021-12-01)